New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
07:12 EDTTEVATeva reports Q4 Generic medicines sales $2.7B, Specialty medicines sales $2.1B
Global revenues recorded by Teva for Copaxone increased 14%, or 15% in local currency terms, to $1.1B compared to $927M in the fourth quarter of 2011. The increase primarily resulted from the take-back of marketing and distribution rights in Europe and continued market share leadership. Reports Q4 Treandra revenue $161M. Azilect revenues recorded by Teva increased 4% to $86M, while global in-market revenues increased 4% to $113M, primarily due to increased demand in the U.S. and Europe and a price increase.
News For TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
10:28 EDTTEVASenate Health, Education, Labor & Pensions Committee to hold a hearing
The Subcommittee on Primary Health and Aging holds a hearing entitled, "Why Are Some Generic Drugs Skyrocketing In Price?" with President & CEO Vigodman of Teva Pharmaceutical and President & CEO Bedrosian of Lannett Company on November 20 at 1 pm. Webcast Link
07:42 EDTTEVAIntellipharmaceutics notes launch of 5mg strength Focalin XR by Teva
Subscribe for More Information
November 18, 2014
11:22 EDTTEVATeva patent victory over Warner Chilcott, Roche affirmed
The U.S. Court of Appeals for the Federal Circuit ruled that a district court was correct to grant summary judgment to Teva (TEVA) in a patent dispute with Warner Chilcott and Roche (RHHBY) over patents related to osteoporosis drug risedronate.
10:08 EDTTEVATeva calls active on renewed takeover chatter
Teva November 57 and 58 calls are active on total call volume of 21K contracts (2K puts) following renewed takeover chatter. November call option implied volatility is at 18, December is at 19; compared to its 26-week average of 24 according to Track Data. Active call volume suggests traders taking positions for upside price movement.
09:47 EDTTEVARumor: Teva moves up on renewed takeover chatter
Subscribe for More Information
08:00 EDTTEVATeva launches liquid formulation of TREANDA injection in the U.S.
Subscribe for More Information
November 7, 2014
08:03 EDTTEVATeva to present albuterol MDPI data at ACAAI
Subscribe for More Information
08:01 EDTTEVATeva announces findings from Phase III QNASL study, says QNASL 'well tolerated'
Subscribe for More Information
05:56 EDTTEVATeva implied volatility of 22 at lower end of index mean range
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use